August 06, 2025 a 07:43 pm
CRL: Fundamental Ratio Analysis - Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. operates in the healthcare sector, providing a wide array of non-clinical services globally. The stock has shown a moderate overall score, with certain fundamental metrics revealing potential for improvement. Investors might consider weighing sector dynamics alongside company-specific insights.
Fundamental Rating
The company's fundamentals receive a grade of 'C', with variable performance across different financial metrics.
| Category | Score | Score Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 1 | |
| Return on Assets | 1 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 3 |
Historical Rating
Current and past scores show stability with room for improvement in most areas.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-08-06 | 2 | 4 | 1 | 1 | 1 | 1 | 3 |
| Previous | 0 | 4 | 1 | 1 | 1 | 1 | 3 |
Analyst Price Targets
The analysts' targets indicate optimism with a notable upside potential. The consensus suggests a 'Buy'.
| High | Low | Median | Consensus |
|---|---|---|---|
| 465 | 151 | 290 | 303.6 |
Analyst Sentiment
A predominant 'Buy' consensus with minimal divergences in sentiment.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 19 | |
| Hold | 16 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Charles River Laboratories International, Inc. presents a balanced investment case, given its strong position in the healthcare industry and existing financial metrics. The stock's fundamental rating suggests room for growth and improvement. Analyst targets are optimistic, supporting the overall 'Buy' sentiment. However, investors should remain cautious of market dynamics and sector shifts. Comprehensive due diligence is recommended before investment.